HHS Fights Court Review In 340B Orphan Drug Row

By Jeff Overley · March 23, 2015, 2:47 PM EDT

The U.S. Department of Health and Human Services is fighting to block court review of its policy on discounts for orphan drugs in the 340B program, telling a D.C. federal judge...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum / Reply

Case Information

Case Title

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA v. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES et al

Case Number

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

October 09, 2014

Recent Articles By Jeff

July 05, 2024
How Reshaped Circuit Courts Are Faring At The High Court
July 05, 2024
The Funniest Moments Of The Supreme Court's Term
June 29, 2024
Chevron's End Is Just The Start For Energized Agency Foes
June 17, 2024
Teva, DOJ Signal Key Kickback Case May Fizzle At 1st Circ.
March 29, 2024
Hogan Lovells Vet's High Court Debut A Study In Contrasts
January 29, 2024
The Top Attys In Clinton's Impeachment Trial, 25 Years Later
January 18, 2024
'Chaos' Warning Resonates As Justices Mull Chevron's Fate
January 01, 2024
Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024
December 09, 2023
Circuit-By-Circuit Guide To 2023's Most Memorable Moments
November 09, 2023
Paul Clement's Big Idea: Overrule Chevron, Ease Polarization